MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS)
Organization & Developments: Pieris
Parents
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS)
Children
2017: 2 ~$5 Biotechs To Buy Here_Pieris, Adamis
2017: Pieris Pharmaceuticals: Favorable Collaboration Terms Point To Continued Upside - Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)
2018: Pieris Pharmaceuticals (PIRS)_This Small Cap Biotech Continues To Charge Ahead - Bret Jensen
2018: Pieris Pharmaceuticals: Management Continues To Execute - Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)
2018: Pieris Pharmaceuticals: Our Take On This $5 Biotech Stock - Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)
2018: Pieris, Seattle Genetics pen $1.2B biobucks pact for next-gen cancer drugs
2019: Pieris Pharmaceuticals: 060 Data Looks Great, What Gives?_seekingalpha.com
2019: Revisiting Pieris Pharmaceuticals_seekingalpha.com
2021: Progress At Pieris Pharmaceuticals
2022: Pieris Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
Jumps
*Key People: Pieris
Finance & Acquisitions: Pieris